An Outbreak of Synthetic Cannabinoid-Adulterated Tianeptine Products in New Jersey – Case Series
These cases represent a marked increase in tianeptine exposures compared with the poison center's historical average. Analytical testing revealed variable product composition, including the presence of synthetic cannabinoids. Clinicians should be aware that tianeptine containing products are widely available, unregulated, and can be adulterated.
Authors
- Howard A. Greller
- Bruce Ruck
- Christopher Counts (ORCID: https://orcid.org/0000-0002-6524-4263)
- Alex J. Krotulski (ORCID: https://orcid.org/0000-0003-1775-1882)
- Diane P. Calello (ORCID: https://orcid.org/0000-0003-1752-847X)
- Oliver L. Hung
- Barry Kerr Logan (ORCID: https://orcid.org/0000-0003-2400-4711)
- Lewis S. Nelson (ORCID: https://orcid.org/0000-0001-9551-3922)
- Anthony V. Spadaro
- Sara E. Walton (ORCID: https://orcid.org/0009-0003-4461-5293)
- Trevor Cerbini
Institutions
- Rutgers, The State University of New Jersey (US)
- New Jersey Department of Education (US)
- Morristown Medical Center (US)
- Fredric Rieders Family Foundation (US)
- Rutgers New Jersey Medical School (US)
Publication Details
- Journal
- Journal of Medical Toxicology
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1007/s13181-025-01068-7
- Citations
- 3
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 4.18